Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vertex to acquire Concert Pharmaceuticals’ cystic fibrosis drug for $250m

pharmaceutical-technologyMarch 08, 2017

Tag: Concert Pharmaceuticals , vertex

PharmaSources Customer Service